N- and C-domains of HIV-1 gp41: mutation, structure and functions

被引:32
作者
Dong, XN
Xiao, Y
Dierich, MP
Chen, YH [1 ]
机构
[1] Tsinghua Univ, Res Ctr Med Sci, Dept Biol Sci & Technol, Immunol Lab, Beijing 100084, Peoples R China
[2] Univ Innsbruck, Ludwig Boltzmann Inst AIDS Res, Inst Hyg, A-6010 Innsbruck, Austria
关键词
HIV-1; gp41; N- and C-domains; structure; function;
D O I
10.1016/S0165-2478(00)00302-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent studies demonstrated that the N- and C-domains of HIV-1 gp41 is involved in virus-mediated membrane fusion resulting in HIV-entry into the target cells. Up to now, viral mutation baffled many scientists to develop effective vaccines and drugs against HIV-1. To acquire more information of mutation of gp41 and to reveal the relationship of structure and function of the N- and C-domains, we compared and analyzed amino acid sequences of the gp41 ectodomain (aa 512-681) of 862 isolates from most HIV-1 clades (including A, B, C, D, E, F, G, H, I, J and O clades). A consensus sequence of the ectodomain with the highest frequency emerging on each position is constituted. The fusion domain and the N-domain belong to the most conserved regions in gp41, and most variable residues assemble partial to the C terminal of gp41. The hydrophobicity of each position is also calculated. The a and d positions in the N-domain for maintaining stabilization of the trimeric coiled coil interactions are highly conservative? and the e and g positions in the C-domain to retain the interaction show also highly conservative. The strange high conservation of the c residues may have an implication in the coiled coil structure. The highly conserved residues form the lining of the hydrophobic cavity and the deep cavity is an ideal target for small molecular inhibitors. On the C-terminal of the C-domain there is a highly conserved segment GIVQQQ. They are intimately involved in forming the three interfaces between neighboring helices. The function of the N- and C-domains, such as binding to the potential cellular receptor and inducing protective activities, are also discussed. These studies on the mutation, structure and functions of the N- and C-domains suggested that both domains become a new focus to develop effective vaccine and antiviral drugs in the new strategies. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:215 / 220
页数:6
相关论文
共 41 条
[1]   OLIGOMERIZATION OF THE HYDROPHOBIC HEPTAD REPEAT OF GP41 [J].
BERNSTEIN, HB ;
TUCKER, SP ;
KAR, SR ;
MCPHERSON, SA ;
MCPHERSON, DT ;
DUBAY, JW ;
LEBOWITZ, J ;
COMPANS, RW ;
HUNTER, E .
JOURNAL OF VIROLOGY, 1995, 69 (05) :2745-2750
[2]   HIV-cell fusion - The viral mousetrap [J].
Binley, J ;
Moore, JP .
NATURE, 1997, 387 (6631) :346-348
[3]  
Buzko OV, 1999, NAT STRUCT BIOL, V6, P906
[4]   Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41 [J].
Caffrey, M ;
Cai, ML ;
Kaufman, J ;
Stahl, SJ ;
Wingfield, PT ;
Covell, DG ;
Gronenborn, AM ;
Clore, GM .
EMBO JOURNAL, 1998, 17 (16) :4572-4584
[5]   EFFECTS OF AMINO-ACID CHANGES IN THE EXTRACELLULAR DOMAIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 ENVELOPE GLYCOPROTEIN [J].
CAO, J ;
BERGERON, L ;
HELSETH, E ;
THALI, M ;
REPKE, H ;
SODROSKI, J .
JOURNAL OF VIROLOGY, 1993, 67 (05) :2747-2755
[6]   Core structure of gp41 from the HIV envelope glycoprotein [J].
Chan, DC ;
Fass, D ;
Berger, JM ;
Kim, PS .
CELL, 1997, 89 (02) :263-273
[7]   Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target [J].
Chan, DC ;
Chutkowski, CT ;
Kim, PS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15613-15617
[8]   HIV entry and its inhibition [J].
Chan, DC ;
Kim, PS .
CELL, 1998, 93 (05) :681-684
[9]   The C domain of HIV-1 gp41 binds the putative cellular receptor protein P62 [J].
Chen, YH ;
Xiao, Y ;
Wu, WC ;
Yang, J ;
Sui, SF ;
Dierich, MP .
AIDS, 1999, 13 (09) :1021-1024
[10]   HIV-1 GP41 CONTAINS 2 SITES FOR INTERACTION WITH SEVERAL PROTEINS ON THE HELPER T-LYMPHOID CELL-LINE, H9 [J].
CHEN, YH ;
EBENBICHLER, C ;
VORNHAGEN, R ;
SCHULZ, TF ;
STEINDL, F ;
BOCK, G ;
KATINGER, H ;
DIERICH, MP .
AIDS, 1992, 6 (06) :533-539